Showing results (1431-1440 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|April 10, 2013
Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumoursZ-F Wu, N Yang, D-Y Li, et al.Journal of Viral Hepatitis|April 10, 2013
Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant womenZ Guo, X H Shi, Y L Feng, et al.Journal of Viral Hepatitis|April 10, 2013
Maternal hepatitis B surface antigen status and incidence of pre-eclampsiaT T Lao, D S Sahota, Y K Y Cheng, et al.Journal of Viral Hepatitis|April 10, 2013
What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behindF AhmedJournal of Viral Hepatitis|July 2, 2013
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis CR Zampino, N Coppola, G Cirillo, et al.Journal of Viral Hepatitis|July 2, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirinM P Manns, P J Pockros, G Norkrans, et al.Journal of Viral Hepatitis|July 2, 2013
Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis CZ M Younossi, M Stepanova, M Afendy, et al.Journal of Viral Hepatitis|July 2, 2013
Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis CK Yanagisawa, S Yue, H J van der Vliet, et al.Journal of Viral Hepatitis|June 9, 2012
Treating hepatitis C: current standard of care and emerging direct-acting antiviral agentsF Poordad, D DieterichJournal of Viral Hepatitis|June 9, 2012
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximabG Geri, B Terrier, F Imbert-Bismut, et al.Pageof 362